Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor

Stem Cell Research and Therapy

Volumn 4, Issue 5, 2013, Pages

  Li, Diangeng ^a   Wang, Nan ^a   Zhang, Li ^a   Hanyu, Zhu ^a   Xueyuan, Bai ^a   Fu, Bo ^a   Shaoyuan, Cui ^a   Zhang, Weiguang ^a   Xuefeng, Sun ^a   Li, Rongshan ^b   Chen, Xiangmei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Diabetic nephropathy; Epithelial growth factor; Injury; Mesenchymal stem cells; Podocyte

Indexed keywords

CASPASE 3; EPITHELIAL GROWTH FACTOR; GLUCOSE; GROWTH FACTOR; NEPHRIN; NEUTRALIZING ANTIBODY; RECOMBINANT CYTOKINE; SYNAPTOPODIN; UNCLASSIFIED DRUG; CULTURE MEDIUM; CYTOKINE; EPIDERMAL GROWTH FACTOR; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; SYNAPTOPHYSIN;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EMBRYO; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; RENAL PROTECTION; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY; SECRETION (PROCESS); TIME;

ADIPOSE TISSUE; ANIMALS; ANTIBODIES, NEUTRALIZING; APOPTOSIS; CASPASE 3; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; EPIDERMAL GROWTH FACTOR; GLUCOSE; HUMANS; MEMBRANE PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; PODOCYTES; RECOMBINANT PROTEINS; SYNAPTOPHYSIN; TIME FACTORS;

EID: 84883164920     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt314     Document Type: Article

References (44)

1. Unchanged distribution density of anionic sites on the glomerular wall in rats with streptozotocin-induced diabetic nephropathy. Shimoi A, Hatakeyama H, Koizumi H, Satoh H, Watanabe M, Toxicol Pathol 2012 40 789 796 10.1177/0192623312441411 22467625
2. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies. Xu ZG, Ryu DR, Yoo TH, Jung DS, Kim JJ, Kim HJ, Choi HY, Kim JS, Adler SG, Natarajan R, Han DS, Kang SW, Nephrol Dial Transplant 2005 20 524 531 10.1093/ndt/gfh642 15647309 (Pubitemid 40378420)
3. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP, Nat Med 2007 13 1349 1358 10.1038/nm1667 17982464 (Pubitemid 350073598)
4. Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. Wang H, Madhusudhan T, He T, Hummel B, Schmidt S, Vinnikov IA, Shahzad K, Kashif M, Muller-Krebs S, Schwenger V, Bierhaus A, Rudofsky G, Nawroth PP, Isermann B, Blood 2011 117 5231 5242 10.1182/blood-2010-10-314773 21389321
5. Podocyte proliferation and differentiation in glomerular disease: role of cell-cycle regulatory proteins. Griffin SV, Petermann AT, Durvasula RV, Shankland SJ, Nephrol Dial Transplant 2003 18 22i8 vi13 12953035
6. Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice. Wang RQ, Nan YM, Wu WJ, Kong LB, Han F, Zhao SX, Kong L, Yu J, Lipids Health Dis 2011 10 31 10.1186/1476-511X-10-31 21314960
7. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE, Diabetes 2009 58 1201 1211 10.2337/db08-1536 19208908
8. Concise review: role of mesenchymal stem cells in wound repair. Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA, Stem Cells Trans Med 2012 1 142 149 10.5966/sctm.2011-0018
9. Isolation and characterization of equine amnion mesenchymal stem cells. Coli A, Nocchi F, Lamanna R, Iorio M, Lapi S, Urciuoli P, Scatena F, Giannessi E, Stornelli MR, Passeri S, Cell Biol Int Rep 2011 18 00011
10. A novel serum-free medium for the expansion of human mesenchymal stem cells. Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC, Stem Cell Res Ther 2010 1 8 10.1186/scrt8 20504289
11. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Schrijvers BF, De Vriese AS, Flyvbjerg A, Endocr Rev 2004 25 971 1010 10.1210/er.2003-0018 15583025 (Pubitemid 39657775)
12. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G, J Am Soc Nephrol 2009 20 1053 1067 10.1681/ASN.2008070798 19389847
13. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C, Am J Physiol Renal Physiol 2005 289 31 F42 10.1152/ajprenal.00007.2005 15713913 (Pubitemid 40863570)
14. Survival and distribution of injected haematopoietic stem cells in acute kidney injury. Burst V, Putsch F, Kubacki T, Volker LA, Bartram MP, Muller RU, Gillis M, Kurschat CE, Grundmann F, Muller-Ehmsen J, Benzing T, Teschner S, Nephrol Dial Transplant 2012 28 1131 1139 23197679
15. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, Bonventre JV, J Clin Invest 2005 115 1743 1755 10.1172/JCI22593 16007251 (Pubitemid 40979713)
16. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Yang Z, Li K, Yan X, Dong F, Zhao C, Graefe's Arch Clin Exp Ophthalmol 2010 248 1415 1422 10.1007/s00417-010-1384-z 23973776
17. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Salgado AJ, Reis RL, Sousa NJ, Gimble JM, Curr Stem Cell Res Ther 2010 5 103 110 10.2174/157488810791268564 19941460
18. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Danchuk S, Ylostalo JH, Hossain F, Sorge R, Ramsey A, Bonvillain RW, Lasky JA, Bunnell BA, Welsh DA, Prockop DJ, Sullivan DE, Stem Cell Res Ther 2011 2 27 10.1186/scrt68 21569482
19. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Susztak K, Raff AC, Schiffer M, Bottinger EP, Diabetes 2006 55 225 233 10.2337/diabetes.55.01.06. db05-0894 16380497 (Pubitemid 43343319)
20. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC, Biochem Biophys Res Commun 2005 332 370 379 10.1016/j.bbrc.2005.04.135 15896706 (Pubitemid 40724988)
21. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. Chen L, Tredget EE, Wu PY, Wu Y, PloS One 2008 3 1886 10.1371/journal.pone.0001886 18382669 (Pubitemid 351943822)
22. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Ben Azouna N, Jenhani F, Regaya Z, Berraeis L, Ben Othman T, Ducrocq E, Domenech J, Stem Cell Res Ther 2012 3 6 10.1186/scrt97 22333342
23. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. Floege J, Kriz W, Schulze M, Susani M, Kerjaschki D, Mooney A, Couser WG, Koch KM, J Clin Invest 1995 96 2809 2819 10.1172/JCI118351 8675651
24. Podocyte injury and targeting therapy: an update. Durvasula RV, Shankland SJ, Curr Opin Nephrol Hypertens 2006 15 1 7 10.1097/01.mnh.0000199012.79670.0b 16340659
25. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. Yanagida-Asanuma E, Asanuma K, Kim K, Donnelly M, Young Choi H, Hyung Chang J, Suetsugu S, Tomino Y, Takenawa T, Faul C, Mundel P, Am J Pathol 2007 171 415 427 10.2353/ajpath.2007.070075 17569780 (Pubitemid 47344675)
26. Pathogenesis and progression of proteinuria. Thomas MC, Contrib Nephrol 2011 170 48 56 21659757
27. Podocytes as a target of prorenin in diabetes. Sakoda M, Itoh H, Ichihara A, Curr Diabetes Rev 2011 7 17 21 10.2174/157339911794273955 21067509
28. Anion exchanger 1 interacts with nephrin in podocytes. Wu F, Saleem MA, Kampik NB, Satchwell TJ, Williamson RC, Blattner SM, Ni L, Toth T, White G, Young MT, Parker MD, Alper SL, Wagner CA, Toye AM, J Am Soc Nephrol 2010 21 1456 1467 10.1681/ASN.2009090921 20576809
29. MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency. Chen YQ, Wang XX, Yao XM, Zhang DL, Yang XF, Tian SF, Wang NS, Am J Nephrol 2011 34 549 559 10.1159/000333809 22123611
30. Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Lee SC, Han SH, Li JJ, Lee SH, Jung DS, Kwak SJ, Kim SH, Kim DK, Yoo TH, Kim JH, Chang SH, Han DS, Kang SW, Kidney Int 2009 76 838 848 10.1038/ki.2009.286 19657327
31. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, Negishi K, Tsuruyama T, Uemoto S, Kobayashi E, PLoS One 2011 6 19195 10.1371/journal.pone.0019195 21559442
32. Mesenchymal stem cells as therapeutics. Parekkadan B, Milwid JM, Annu Rev Biomed Eng 2010 12 87 117 10.1146/annurev-bioeng-070909-105309 20415588
33. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. Wang N, Li Q, Zhang L, Lin H, Hu J, Li D, Shi S, Cui S, Zhou J, Ji J, Wan J, Cai G, Chen X, PloS One 2012 7 43768 10.1371/journal.pone.0043768 22912904
34. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ, Nat Med 2005 11 367 368 10.1038/nm0405-367 15812508 (Pubitemid 40562318)
35. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, Ordener C, Piercecchi-Marti MD, Auge N, Salvayre AN, Bourin P, Parini A, Cussac D, Stem Cells 2009 27 2734 2743 10.1002/stem.169 19591227
36. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Yoon BS, Moon JH, Jun EK, Kim J, Maeng I, Kim JS, Lee JH, Baik CS, Kim A, Cho KS, Lee HH, Whang KY, You S, Stem Cells Dev 2010 19 887 902 10.1089/scd.2009.0138 19686050
37. Perspectives on mesenchymal stem cells: tissue repair, immune modulation, and tumor homing. Hong HS, Kim YH, Son Y, Arch Pharm Res 2012 35 201 211 10.1007/s12272-012-0201-0 22370775
38. Characterization of adipose-derived stem cells: an update. Bailey AM, Kapur S, Katz AJ, Curr Stem Cell Res Ther 2010 5 95 102 10.2174/ 157488810791268555 19941461
39. EGF-recruited JunD/c-fos complexes activate CD2AP gene promoter and suppress apoptosis in renal tubular epithelial cells. Lu C, Ren W, Su XM, Chen JQ, Wu SH, Zhou GP, Gene 2009 433 56 64 10.1016/j.gene.2008.11.015 19095050
40. EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells. Ying WZ, Zhang HG, Sanders PW, J Am Soc Nephrol 2007 18 131 142 10.1681/ASN.2006040333 17151333 (Pubitemid 46053428)
41. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Yew TL, Hung YT, Li HY, Chen HW, Chen LL, Tsai KS, Chiou SH, Chao KC, Huang TF, Chen HL, Hung SC, Cell Transplant 2011 20 693 706 10.3727/096368910X550198 21176394
42. Epidermal growth factor receptor signaling modulates apoptosis via p38alpha MAPK-dependent activation of Bax in intestinal epithelial cells. Sheng G, Guo J, Warner BW, Am J Physiol Gastrointest Liver Physiol 2007 293 599 G606 10.1152/ajpgi.00182.2007 17615176 (Pubitemid 47435380)
43. EGF activates an inducible survival response via the RAS- > Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells. Caraglia M, Tagliaferri P, Marra M, Giuberti G, Budillon A, Gennaro ED, Pepe S, Vitale G, Improta S, Tassone P, Venuta S, Bianco AR, Abbruzzese A, Cell Death Differ 2003 10 218 229 10.1038/sj.cdd.4401131 12700650 (Pubitemid 36553464)
44. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Bollee G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M, Schordan E, Sabaa N, Vandermeersch S, Galaup A, Rodenas A, Casal I, Sunnarborg SW, Salant DJ, Kopp JB, Threadgill DW, Quaggin SE, Dussaule JC, Germain S, Mesnard L, Endlich K, Boucheix C, Belenfant X, Callard P, Endlich N, Tharaux PL, Nat Med 2011 17 1242 1250 10.1038/nm.2491 21946538